There have been 50 recent insider transactions recorded for Cue Biopharma, Inc. (CUE), including 44 buys and 0 sells. Total insider buying was valued at $7.56M and total insider selling at RSU Award.
Notable insiders with recent activity include Broadfoot Jill Marie, Kiener Peter A, Morich Frank. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — CUE
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-01-02 |
Broadfoot Jill Marie |
Director |
RSU Award |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2026-01-02 |
Kiener Peter A |
Director |
RSU Award |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2026-01-02 |
Morich Frank |
Director |
RSU Award |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2026-01-02 |
Verheyen Patrick |
Director |
RSU Award |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2026-01-02 |
Garzone Pamela |
Director |
RSU Award |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2026-01-02 |
Sarraf Pasha |
Director |
RSU Award |
24,400 |
$0.34 |
$8.3K |
24,400 |
| 2025-12-30 |
Sarraf Pasha |
Director |
Informative Buy |
4,229 |
$0.31 |
$1.31K |
4,229 |
| 2025-12-03 |
Sandercock Colin |
SVP, General Counsel |
RSU Award |
70,000 |
$0.70 |
$49K |
70,000 |
| 2025-09-29 |
Azam Usman |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-09-29 |
Azam Usman |
Chief Executive Officer |
RSU Award |
1,875,000 |
$0.72 |
$1.35M |
1,875,000 |
| 2025-09-29 |
Warren Lucinda |
Chief Business Officer |
RSU Award |
125,000 |
$0.72 |
$90K |
125,000 |
| 2025-09-29 |
Baker Daniel G. |
Chief Development Officer |
RSU Award |
50,000 |
$0.72 |
$36K |
50,000 |
| 2025-09-26 |
Sandercock Colin |
SVP, General Counsel |
RSU Award |
30,000 |
$0.70 |
$21K |
30,000 |
| 2025-06-04 |
Broadfoot Jill Marie |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-06-04 |
Broadfoot Jill Marie |
Director |
RSU Award |
48,800 |
$0.62 |
$30.26K |
48,800 |
| 2025-03-21 |
Passeri Daniel R |
Chief Executive Officer |
RSU Award |
450,000 |
$0.99 |
$445.5K |
450,000 |
| 2025-03-21 |
Sandercock Colin |
SVP, General Counsel |
RSU Award |
200,000 |
$0.99 |
$198K |
200,000 |
| 2025-03-21 |
Millar Kerri-ann |
Chief Financial Officer |
RSU Award |
200,000 |
$0.99 |
$198K |
200,000 |
| 2025-03-21 |
Levisetti Matteo |
Chief Medical Officer |
RSU Award |
250,000 |
$0.99 |
$247.5K |
250,000 |
| 2025-03-21 |
Warren Lucinda |
Chief Business Officer |
RSU Award |
250,000 |
$0.99 |
$247.5K |
250,000 |
| 2025-03-21 |
Baker Daniel G. |
Chief Development Officer |
RSU Award |
100,000 |
$0.99 |
$99K |
100,000 |
| 2025-03-10 |
Sarraf Pasha |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-03-10 |
Sarraf Pasha |
Director |
RSU Award |
48,800 |
$1.03 |
$50.26K |
48,800 |
| 2025-01-02 |
Driscoll Frederick W |
Director |
RSU Award |
24,400 |
$1.09 |
$26.6K |
24,400 |
| 2025-01-02 |
Kiener Peter A |
Director |
RSU Award |
24,400 |
$1.09 |
$26.6K |
24,400 |
| 2025-01-02 |
Morich Frank |
Director |
RSU Award |
24,400 |
$1.09 |
$26.6K |
24,400 |
| 2025-01-02 |
Verheyen Patrick |
Director |
RSU Award |
24,400 |
$1.09 |
$26.6K |
24,400 |
| 2025-01-02 |
Garzone Pamela |
Director |
RSU Award |
24,400 |
$1.09 |
$26.6K |
24,400 |
| 2024-12-16 |
Passeri Daniel R |
Chief Executive Officer |
Informative Buy |
30,000 |
$1.03 |
$30.9K |
164,578 |
| 2024-11-25 |
Baker Daniel G. |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-11-25 |
Baker Daniel G. |
Chief Development Officer |
RSU Award |
200,000 |
$1.06 |
$212K |
200,000 |
| 2024-09-03 |
Warren Lucinda |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-09-03 |
Warren Lucinda |
Chief Business Officer |
RSU Award |
350,000 |
$0.66 |
$231K |
350,000 |
| 2024-06-05 |
Fox Michael J |
Director |
Unknown |
- |
- |
- |
100,000 |
| 2024-06-05 |
Fox Michael J |
Director |
RSU Award |
48,800 |
$1.65 |
$80.52K |
48,800 |
| 2024-06-05 |
Sandercock Colin |
SVP, General Counsel |
RSU Award |
60,000 |
$1.65 |
$99K |
60,000 |
| 2024-06-05 |
Millar Kerri-ann |
Chief Financial Officer |
RSU Award |
60,000 |
$1.65 |
$99K |
60,000 |
| 2024-06-05 |
Suri Anish |
President and CSO |
RSU Award |
150,000 |
$1.65 |
$247.5K |
150,000 |
| 2024-06-05 |
Levisetti Matteo |
Chief Medical Officer |
RSU Award |
125,000 |
$1.65 |
$206.25K |
125,000 |
| 2024-03-06 |
Passeri Daniel R |
Chief Executive Officer |
RSU Award |
400,000 |
$1.94 |
$776K |
400,000 |
| 2024-03-06 |
Sandercock Colin |
SVP, General Counsel |
RSU Award |
175,000 |
$1.94 |
$339.5K |
175,000 |
| 2024-03-06 |
Millar Kerri-ann |
Chief Financial Officer |
RSU Award |
250,000 |
$1.94 |
$485K |
250,000 |
| 2024-03-06 |
Suri Anish |
President and CSO |
RSU Award |
300,000 |
$1.94 |
$582K |
300,000 |
| 2024-03-06 |
Levisetti Matteo |
Chief Medical Officer |
RSU Award |
260,000 |
$1.94 |
$504.4K |
260,000 |
| 2024-02-20 |
Levisetti Matteo |
Chief Medical Officer |
RSU Award |
25,000 |
$3.36 |
$84K |
25,000 |
| 2024-01-02 |
Driscoll Frederick W |
Director |
RSU Award |
24,400 |
$2.78 |
$67.83K |
24,400 |
| 2024-01-02 |
Kiener Peter A |
Director |
RSU Award |
24,400 |
$2.78 |
$67.83K |
24,400 |
| 2024-01-02 |
Morich Frank |
Director |
RSU Award |
24,400 |
$2.78 |
$67.83K |
24,400 |
| 2024-01-02 |
Verheyen Patrick |
Director |
RSU Award |
24,400 |
$2.78 |
$67.83K |
24,400 |
| 2024-01-02 |
Garzone Pamela |
Director |
RSU Award |
24,400 |
$2.78 |
$67.83K |
24,400 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
